LOAMU
EBS icon

Lombard Odier Asset Management (USA)’s Emergent Biosolutions EBS Stock Holding History

Lombard Odier Asset Management (USA)’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-7,500
Closed -$434K – 261
2020
Q1 		$434K Buy
+7,500
New +$432K 0.05% 168

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Lombard Odier Asset Management (USA)'s EBS Position: Q2 2020 in Review

Lombard Odier Asset Management (USA) sold out of Emergent Biosolutions (EBS) in Q2 2020, closing a stake of 7,500 shares — an estimated $434K sold.

Lombard Odier Asset Management (USA) first reported a position in EBS in Q1 2020 and held it in 1 quarter. The position peaked at $434K in Q1 2020. 299 funds tracked by Wall St. Rank hold EBS as of Q2 2020.

  • Lombard Odier Asset Management (USA) reported no remaining Emergent Biosolutions position as of Q2 2020 after selling out during the quarter.
  • Lombard Odier Asset Management (USA) sold 7,500 Emergent Biosolutions shares in Q2 2020, an estimated $434K.
  • Lombard Odier Asset Management (USA) first reported a position in Emergent Biosolutions in Q1 2020 and held it in 1 quarter.
  • Lombard Odier Asset Management (USA)'s Emergent Biosolutions position peaked at $434K in Q1 2020.
  • 299 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2020.

Based on Lombard Odier Asset Management (USA)'s 13F filing for Q2 2020, filed 14 Aug 2020.